STRENGTHING CLINICAL TRIALS FOR CANADIANS
RENFORCEMENT DES ESSAIS CLINIQUES POUR LES CANADIENS
About
Executive Committee
Initiatives
Canadian Clinical Trials Asset Map (CCTAM)
model Clinical Trials Agreement (mCTA)
Provincial Clinical Trials Organisations’ Meetings
Investment Case – “Clinical Trials -the Canadian Advantage”
Report on the Canadian experience of Research Ethics Boards (REBs) harmonisation and centralisation
Clinical Trials Metrics Platform
Reports
2018 Strategic Planning Report: A Pan-Canadian Clinical Trial Strategy
The CCTCC 2014-2017 Report to Stakeholders
Investment Case – “Clinical Trials -the Canadian Advantage”
News
Contact
About
Executive Committee
Initiatives
Canadian Clinical Trials Asset Map (CCTAM)
model Clinical Trials Agreement (mCTA)
Provincial Clinical Trials Organisations’ Meetings
Investment Case – “Clinical Trials -the Canadian Advantage”
Report on the Canadian experience of Research Ethics Boards (REBs) harmonisation and centralisation
Clinical Trials Metrics Platform
Reports
2018 Strategic Planning Report: A Pan-Canadian Clinical Trial Strategy
The CCTCC 2014-2017 Report to Stakeholders
Investment Case – “Clinical Trials -the Canadian Advantage”
News
Contact
Our Initiatives
timeline-edited
Facilitating
Collaboration
Across
Canada
Speeding-Up
Clinical Trials
Start-Up Times
Promoting
Canada as a
Leading Destination
for Clinical Trials
Funding
Provided
Environmental
Pulse Check
Model Clinical Trial Agrement (mCTA)
Due 2017
Fair Market Value Project
Work Started in 2016
Patient Registries
Ongoing
Canadian Clinical Trials Asset Map (CCTAM)
Launched June 2015
Canadian Clinical
Research Participation Survey
Results after March 2017
Provincial Clinical Trials
Organizations Meetings
1. November 2015
2. April 2016
3. November 2016
National Advisory Group
Est. September 2014
Clinical Trials Panel at BIO 2016
June 2016
Investment Case
Launched Summer 2016
Clinical Trials Metrics Platform
Due 2017
Research Ethics Boards Issues
Report released Summer 2016
About
Executive Committee
Initiatives
Canadian Clinical Trials Asset Map (CCTAM)
model Clinical Trials Agreement (mCTA)
Provincial Clinical Trials Organisations’ Meetings
Investment Case – “Clinical Trials -the Canadian Advantage”
Report on the Canadian experience of Research Ethics Boards (REBs) harmonisation and centralisation
Clinical Trials Metrics Platform
Reports
2018 Strategic Planning Report: A Pan-Canadian Clinical Trial Strategy
The CCTCC 2014-2017 Report to Stakeholders
Investment Case – “Clinical Trials -the Canadian Advantage”
News
Contact
